PubRank

W C Wood

Author PubWeight™ 141.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011 13.95
2 Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007 7.33
3 Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst 1998 4.43
4 Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group. JAMA 1994 4.01
5 c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 1994 3.89
6 Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet 2008 2.91
7 A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 1996 2.49
8 Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery 1970 2.34
9 Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. J Clin Oncol 1995 2.33
10 Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst 1993 2.15
11 Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 1990 2.11
12 Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg 1981 1.86
13 Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg 1982 1.72
14 Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann Surg 1970 1.68
15 Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer 1985 1.62
16 Skin-sparing mastectomy. Oncologic and reconstructive considerations. Ann Surg 1997 1.61
17 Clinical validation of an autoantibody test for lung cancer. Ann Oncol 2010 1.55
18 Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 2000 1.54
19 Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg 1999 1.51
20 Early discharge after modified radical mastectomy. Am J Surg 1986 1.47
21 Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol 1996 1.43
22 A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg 1981 1.38
23 Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg 1982 1.38
24 Carcinoid tumors of the appendix. Ann Surg 1993 1.36
25 A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery 1981 1.33
26 Sarcomas of the gastrointestinal tract. Separation into favorable and unfavorable prognostic groups by mitotic count. Ann Surg 1991 1.30
27 Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes. Cancer 1981 1.30
28 Radiation therapy of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1984 1.30
29 Treatment of the patient with stage M0 soft tissue sarcoma. J Clin Oncol 1988 1.29
30 Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study (2192). Am J Clin Oncol 2001 1.26
31 Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma. J Clin Oncol 1991 1.26
32 A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. Ann Surg 1982 1.24
33 Preoperative radiation therapy for sarcoma of soft tissue. Cancer 1981 1.12
34 Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma. Cancer 1991 1.11
35 Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma. Ann Surg 1984 1.11
36 Tumor-specific gene expression using the survivin promoter is further increased by hypoxia. Gene Ther 2004 1.11
37 Intraoperative irradiation for unresectable pancreatic carcinoma. Cancer 1982 1.11
38 Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 1995 1.09
39 Postoperative radiation therapy of rectal cancer. Int J Radiat Oncol Biol Phys 1987 1.08
40 Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. J Clin Oncol 1996 1.07
41 Residual, unresectable, or recurrent colorectal cancer: external beam irradiation and intraoperative electron beam boost +/- resection. Int J Radiat Oncol Biol Phys 1983 1.04
42 Pathological studies in rectal cancer. Cancer 1980 1.03
43 Doxorubicin chemotherapy in the treatment of soft-tissue sarcoma. Combined results of two randomized trials. Arch Surg 1986 1.01
44 Host immune response to a common cell-surface antigen in human sarcomas. N Engl J Med 1971 1.01
45 A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. Am J Surg 1981 1.01
46 Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196. J Clin Oncol 2000 0.98
47 The role of misonidazole combined with intraoperative radiation therapy in the treatment of pancreatic carcinoma. J Clin Oncol 1987 0.98
48 Benign smooth muscle tumors of the gastrointestinal tract. A 24-year experience. Ann Surg 1990 0.97
49 Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis. J Am Acad Dermatol 1983 0.96
50 Patterns of failure following local excision and local excision and postoperative radiation therapy for invasive rectal adenocarcinoma. J Clin Oncol 1989 0.96
51 Fifth International Conference on Adjuvant Therapy of Breast Cancer, St Gallen, March 1995. International Consensus Panel on the Treatment of Primary Breast Cancer. Eur J Cancer 1995 0.96
52 The management of ductal and lobular breast cancer. Surg Oncol 1999 0.95
53 Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group Study. J Clin Oncol 1999 0.92
54 Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump. Cancer 1983 0.90
55 Reversal of selenium deficiency with oral selenium. N Engl J Med 1981 0.90
56 Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy. A subset analysis of CALGB Study 8081. Cancer 1988 0.89
57 pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival. Breast Cancer Res Treat 1992 0.89
58 Regional hepatic chemotherapy using an implantable drug infusion pump. Am J Surg 1983 0.89
59 Cytotoxic antibody responses in astrocytoma patients. An improved allogeneic assay. J Neurosurg 1979 0.89
60 Intraoperative electron beam radiotherapy in the treatment of unresectable rectal cancer. Arch Surg 1986 0.88
61 Multivariate analysis. Some guidelines for physicians. JAMA 1983 0.88
62 Carotenoids, retinol, and vitamin E and risk of proliferative benign breast disease and breast cancer. Cancer Causes Control 1992 0.87
63 Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma. Surgery 1978 0.87
64 Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays. J Natl Cancer Inst 1980 0.87
65 Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer. Breast 2003 0.87
66 Conservative treatment of early-stage breast cancer in a medically indigent population. J Natl Med Assoc 1995 0.87
67 Adjuvant postoperative radiation therapy for rectal adenocarcinoma. Am J Clin Oncol 1992 0.86
68 Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma. Cancer 1991 0.86
69 Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma: phase I-II study. Radiology 1993 0.86
70 Intravenous dipyridamole thallium-201 SPECT imaging in patients with left bundle branch block. Clin Nucl Med 1990 0.85
71 Immediate breast reconstruction for stage III breast cancer using transverse rectus abdominis musculocutaneous (TRAM) flap. Ann Surg Oncol 1996 0.85
72 Prognosis of clinical stage I melanoma patients with positive elective regional node dissection. J Clin Oncol 1986 0.85
73 Combined modality treatment of gastric cancer. Int J Radiat Oncol Biol Phys 1983 0.84
74 Adjuvant chemotherapy in the node-negative breast cancer patient. Surg Clin North Am 1996 0.84
75 Enteric duplication presenting as cystic tumors of the pancreas. Surgery 1997 0.84
76 Anti-metastatic prostacyclins inhibit the adhesion of colon carcinoma to endothelial cells by blocking E-selectin expression. Clin Exp Metastasis 1996 0.83
77 Intraoperative electron beam radiation therapy boost in the treatment of recurrent rectal cancer. Dis Colon Rectum 1980 0.82
78 Microcytotoxicity test: detection in sarcoma patients of antibody cytotoxic to human sarcoma cells. Science 1970 0.81
79 Treatment of carcinoma of the breast in the older geriatric patient. Surg Gynecol Obstet 1991 0.81
80 Preoperative irradiation for tethered rectal carcinoma. Radiother Oncol 1991 0.81
81 Does preoperative needle localization lead to an increase in local breast cancer recurrence? Radiology 1988 0.80
82 Implications for clinical management in patients with breast cancer. Long-term effects of reconstruction surgery. Cancer 1991 0.80
83 Sensitivity and specificity of serum ribonuclease in the diagnosis of pancreatic cancer. Am J Surg 1980 0.80
84 Cytotoxicity of human brain tumors by hematoporphyrin derivative. J Surg Res 1986 0.80
85 Intraoperative +/- external beam irradiation. Curr Probl Cancer 1983 0.79
86 Adjuvant postoperative radiation therapy for colonic carcinoma. Ann Surg 1987 0.79
87 Human astrocytoma: serum-mediated immunologic response. Cancer 1974 0.79
88 Treatment of colorectal cancer hepatic metastases by hepatic artery chemotherapy. Dis Colon Rectum 1985 0.79
89 Palpable breast masses. The importance of preoperative mammography. JAMA 1981 0.79
90 Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study. Am J Med 1989 0.79
91 Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study. Cancer Treat Rep 1985 0.79
92 Radiation and conservative surgery in the treatment of soft tissue sarcoma. Am J Surg 1984 0.78
93 A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study. World J Surg 1985 0.78
94 Carcinoembryonic antigen levels as an indicator for reoperation in patients with carcinoma of the colon and rectum. Surg Gynecol Obstet 1979 0.78
95 Hyperglycemic complications associated with adjuvant chemotherapy of breast cancer. A cancer and leukemia group B (CALGB) study. Am J Clin Oncol 1986 0.78
96 Blalock-Taussig shunts in the infant. Ann Thorac Surg 1973 0.78
97 Indications for adjuvant radiotherapy in extrapelvic colonic carcinoma. Oncology (Williston Park) 1989 0.77
98 Continuous canine epidural morphine analgesia with an implanted drug infusion pump. J Surg Res 1982 0.77
99 Carcinoembryonic antigen release from colorectal cancer cells in tissue culture. J Surg Res 1979 0.77
100 Cytotoxic antibodies in preoperative glioma patients: a diagnostic assay. Acta Neurochir (Wien) 1976 0.77
101 Inflammatory breast carcinoma treated by radical radiotherapy. Cancer 1980 0.77
102 Detection of humoral immune response to human brain tumors: specificity and reliability of microcytotoxicity assay. Cancer 1979 0.77
103 Hepatocellular carcinoma presenting as a pancreatic head mass: report of an unusual case. Am J Clin Oncol 1997 0.77
104 Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study. Cancer Treat Rep 1982 0.76
105 Dermatofibrosarcoma protuberans treated with radiation therapy. Int J Radiat Oncol Biol Phys 1989 0.76
106 Treatment of intraductal carcinoma with limited surgery: long-term follow-up. J Clin Oncol 1989 0.76
107 Transbrachial hepatic arterial chemotherapy using an implanted infusion pump. Dis Colon Rectum 1980 0.76
108 Audit of Cancer and Leukemia Group B data. N Engl J Med 1994 0.75
109 Carcinoma of the breast. Ann Surg 1993 0.75
110 Autologous serologic responses in glioma patients. Correlation with tumor grade and survival. Cancer 1983 0.75
111 Effect of route of administration on the selectivity of hematoporphyrin derivative for tumor tissue. J Surg Oncol 1987 0.75
112 Local administration of orgotein in horses. Mod Vet Pract 1974 0.75
113 II. Postpuerperal Psoitis. Ann Surg 1899 0.75
114 A festschrift to John Elias Skandalakis, M.D., Ph.D., F.A.C.S. Am Surg 2000 0.75
115 Adjuvant therapy in malignant melanoma: a trial of immunotherapy. chemotherapy, and combined treatment. Recent Results Cancer Res 1978 0.75
116 Potential for improvement in radiation therapy. Int J Radiat Oncol Biol Phys 1988 0.75
117 Neoadjuvant chemotherapy. Cancer Treat Res 1992 0.75
118 IX. International consensus conference on primary treatment of breast cancer. Recent Results Cancer Res 1996 0.75
119 Cellulitis of the breast as a complication of breast-conserving surgery and irradiation. Am J Clin Oncol 1997 0.75
120 Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study. Cancer Treat Rep 1983 0.75
121 Radiation therapy and conservative surgery for sarcoma of soft tissue. Prog Clin Cancer 1982 0.75
122 Postobstructive diuresis complicating relief of lower urinary tract obstruction by uterine leiomyomas. Obstet Gynecol 1970 0.75
123 I. On the Treatment of Flat-foot. Ann Surg 1892 0.75
124 Conservative treatment of early-stage breast cancer. The Emory experience. Am J Clin Oncol 1994 0.75
125 Lysis of allogeneic tissue cultured colorectal cancer cells by blood group isoantibody in normal human serum. J Surg Res 1979 0.75
126 Treatment of locally advanced rectal cancer with external beam radiation, surgical resection, and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 1989 0.75
127 Cancer and Leukemia Group B adjuvant chemotherapy trials in postmastectomy breast cancer patients. Breast Cancer Res Treat 1983 0.75
128 Alternative strategies in the management of primary breast cancer. Arch Surg 1998 0.75
129 Putting a price on radiation. J Policy Anal Manage 1983 0.75
130 Serological evaluation of human brain tumors using a microradioisotopic staphylococcal protein A assay. J Surg Oncol 1980 0.75
131 Exercise testing in healthy men. Trans Assoc Life Insur Med Dir Am 1985 0.75
132 Associated coarctation of the aorta and mitral valve disease: nine cases with surgical correction of both lesions in three. J Pediatr 1975 0.75
133 Mechanisms of humoral cytotoxicity testing: the role of rabbit serum, xenoantibody, and human IgM. J Immunol 1977 0.75
134 Microradioisotopic techniques for the detection of antibody to adherent target cells in tissue culture. J Surg Res 1979 0.75
135 Quality control parameters of intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 1986 0.75
136 Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the Cancer and Leukemia Group B. Cancer 1991 0.75
137 Bisantrene (NSC 337766) (CL 216,942) in advanced breast cancer. A cancer and leukemia group B study. Cancer Chemother Pharmacol 1984 0.75
138 Reversal of biochemical and functional abnormalities in erythrocytes secondary to selenium deficiency. JPEN J Parenter Enteral Nutr 1983 0.75
139 Symposium overview: estrogens and antiestrogens in managing the patient with breast cancer. Ann Surg Oncol 2000 0.75
140 Adjuvant therapy for melanoma. Surgery 1983 0.75
141 Should axillary dissection be performed in patients with DCIS? Ann Surg Oncol 1995 0.75
142 Simplified technique for placement of long term central venous silicone catheters. Surg Gynecol Obstet 1982 0.75
143 Microcytotoxicity blocking assay for the detection and isolation of soluble astrocytoma association antigen. J Surg Oncol 1984 0.75
144 Intraoperative radiation therapy. Important Adv Oncol 1985 0.75
145 Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642. J Clin Oncol 1999 0.75
146 Contralateral prophylactic mastectomies. Ann Surg Oncol 1999 0.75